Recruiting families at risk for hereditary breast and ovarian cancer from a statewide cancer registry: a methodological study

被引:17
|
作者
Katapodi, Maria C. [1 ,2 ]
Duquette, Deb [3 ]
Yang, James J. [2 ]
Mendelsohn-Victor, Kari [2 ]
Anderson, Beth [3 ]
Nikolaidis, Christos [1 ]
Mancewicz, Emily [2 ]
Northouse, Laurel L. [2 ]
Duffy, Sonia [4 ]
Ronis, David [2 ]
Milliron, Kara J. [5 ]
Probst-Herbst, Nicole [6 ]
Merajver, Sofia D. [7 ]
Janz, Nancy K. [8 ]
Copeland, Glenn [9 ]
Roberts, Scott [8 ]
机构
[1] Fac Med, Nursing Sci, Bernoullistr 28, CH-4056 Basel, Switzerland
[2] Univ Michigan, Sch Nursing, 400 North Ingalls Bldg, Ann Arbor, MI 48109 USA
[3] Michigan Dept Hlth & Human Serv, 333 S Grand Ave,POB 30195, Lansing, MI 48909 USA
[4] Ohio State Univ, Coll Nursing, 1585 Neil Ave, Columbus, OH 43210 USA
[5] Univ Michigan, Ctr Comprehens Canc, 1500 East Med Ctr Dr,CCGC 6-303, Ann Arbor, MI 48109 USA
[6] Univ Basel, Swiss Trop & Publ Hlth Inst, Socinstr 57, CH-4051 Basel, Switzerland
[7] Univ Michigan, Sch Med, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA
[8] Univ Michigan, Sch Publ Hlth, 1415 Washington Hts, Ann Arbor, MI 48109 USA
[9] Michigan Canc Surveillance Program, 333 S Grand Ave,POB 30195, Lansing, MI 48909 USA
关键词
Young breast cancer survivors; At-risk relatives; Cancer registry; Recruitment; Public health genomic trials; PUBLIC-HEALTH GENOMICS; COLORECTAL-CANCER; RELATIVES; WOMEN; BRCA; PARTICIPATION; INTERVENTION; NOTIFICATION; DESIGN;
D O I
10.1007/s10552-017-0858-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer genetic services (counseling/testing) are recommended for women diagnosed with breast cancer younger than 45 years old (young breast cancer survivors-YBCS) and at-risk relatives. We present recruitment of YBCS, identification and recruitment of at-risk relatives, and YBCS willingness to contact their cancer-free, female relatives. A random sample of 3,000 YBCS, stratified by race (Black vs. White/Other), was identified through a population-based cancer registry and recruited in a randomized trial designed to increase use of cancer genetic services. Baseline demographic, clinical, and family characteristics, and variables associated with the Theory of Planned Behavior (TPB) were assessed as predictors of YBCS' willingness to contact at-risk relatives. The 883 YBCS (33.2% response rate; 40% Black) who returned a survey had 1,875 at-risk relatives and were willing to contact 1,360 (72.5%). From 853 invited at-risk relatives (up to two relatives per YBCS), 442 responded (51.6% response rate). YBCS with larger families, with a previous diagnosis of depression, and motivated to comply with recommendations from family members were likely to contact a greater number of relatives. Black YBCS were more likely to contact younger relatives and those living further than 50 miles compared to White/Other YBCS. It is feasible to recruit diverse families at risk for hereditary cancer from a population-based cancer registry. This recruitment approach can be used as a paradigm for harmonizing processes and increasing internal and external validity of large-scale public health genomic initiatives in the era of precision medicine.
引用
收藏
页码:191 / 201
页数:11
相关论文
共 50 条
  • [1] Recruiting families at risk for hereditary breast and ovarian cancer from a statewide cancer registry: a methodological study
    Maria C. Katapodi
    Deb Duquette
    James J. Yang
    Kari Mendelsohn-Victor
    Beth Anderson
    Christos Nikolaidis
    Emily Mancewicz
    Laurel L. Northouse
    Sonia Duffy
    David Ronis
    Kara J. Milliron
    Nicole Probst-Herbst
    Sofia D. Merajver
    Nancy K. Janz
    Glenn Copeland
    Scott Roberts
    Cancer Causes & Control, 2017, 28 : 191 - 201
  • [2] A Pilot study of the Sharing Risk Information Tool (ShaRIT) for Families with Hereditary Breast and Ovarian Cancer Syndrome
    Kardashian, Ani
    Fehniger, Julia
    Creasman, Jennifer
    Cheung, Eleanor
    Beattie, Mary Stanley
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2012, 10
  • [3] Implementing a Screening Tool for Identifying Patients at Risk for Hereditary Breast and Ovarian Cancer: A Statewide Initiative
    Traxler, L. Brannon
    Martin, Monique L.
    Kerber, Alice S.
    Bellcross, Cecelia A.
    Crane, Barbara E.
    Green, Victoria
    Matthews, Roland
    Paris, Nancy M.
    Gabram, Sheryl G. A.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (10) : 3342 - 3347
  • [4] Guideline for the prevention and early detection of breast and ovarian cancer in high risk patients, particularly in women from HBOC (hereditary breast and ovarian cancer) families
    Singer, Christian F.
    Tea, Muy-Kheng
    Pristauz, Gunda
    Hubalek, Michael
    Rappaport, Christine
    Riedl, Christopher
    Helbich, Thomas
    WIENER KLINISCHE WOCHENSCHRIFT, 2012, 124 (9-10) : 334 - 339
  • [5] Screening for Individuals at Risk for Hereditary Breast and Ovarian Cancer: A Statewide Initiative, Georgia, 2012-2020
    Veitinger, Julia K.
    Kerber, Alice S.
    Gabram-Mendola, Sheryl G. A.
    Liu, Yuan
    Durham, Lynn M.
    Durrence, Diane
    Berzen, Alissa K.
    Shin, Janet Y.
    Snyder, Cindy
    Bellcross, Cecelia A.
    Guan, Yue
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2022, 112 (09) : 1249 - 1252
  • [6] Is there an adequate transfer of information in families with hereditary breast and ovarian cancer?
    Scholl, Eva
    Grimm, Tiemo
    Krockenberger, Mathias
    Kunstmann, Erdmute
    MEDIZINISCHE GENETIK, 2015, 27 (02) : 223 - 227
  • [7] Clinical Practice Guideline for the prevention and early detection of breast and ovarian cancer in women from HBOC (hereditary breast and ovarian cancer) families
    C.F. Singer
    M.K. Tea
    G. Pristauz
    M. Hubalek
    C. Rappaport
    C.C. Riedl
    T.H. Helbich
    Wiener klinische Wochenschrift, 2015, 127 : 981 - 986
  • [8] Pathology of Hereditary Breast and Ovarian Cancer
    Hodgson, Anjelica
    Turashvili, Gulisa
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [9] Clinical Practice Guideline for the prevention and early detection of breast and ovarian cancer in women from HBOC (hereditary breast and ovarian cancer) families
    Singer, C. F.
    Tea, M. K.
    Pristauz, G.
    Hubalek, M.
    Rappaport, C.
    Riedl, C. C.
    Helbich, T. H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2015, 127 (23-24) : 981 - 986
  • [10] Hereditary breast and ovarian cancer
    Lax, S. F.
    PATHOLOGE, 2017, 38 (03): : 149 - 155